Drug Search Results
Using advanced filters...
Advanced Search [+]

Oral salmon calcitonin

Alternative Names: oral salmon calcitonin
Latest Update: 2021-04-14
Latest Update Note: PubMed Publication

Product Description

For the Treatment of Subjects With Knee Osteoarthritis (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00486434)

Mechanisms of Action: Calcitonin Receptor Stimulant

Novel Mechanism: Yes

Modality: Peptide/Protein

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Nordic Bioscience
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Osteoarthritis, Knee

Phase 2: Osteoarthritis

Phase 1: Osteoporosis, Postmenopausal|Osteoarthritis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

OA 2 Study

P3

Terminated

Osteoarthritis, Knee

2011-05-01

CSMC021A2112

P1

Completed

Osteoporosis, Postmenopausal

None

CSMC021C2102

P1

Completed

Osteoarthritis

None

CSMC021A2111

P1

Completed

Osteoporosis, Postmenopausal

None

Recent News Events